Supercharging the peptide boom
The FDA is considering easing restrictions on peptide therapies, which are marketed for their potential to heal injuries and promote muscle growth. Health Secretary Robert F. Kennedy Jr. aims to make about 14 peptide therapies more accessible, but critics warn of safety concerns and evidence gaps.
The FDA may ease restrictions on peptide therapies. Peptides are the building blocks of proteins and are marketed for healing injuries and promoting muscle growth. Health Secretary Robert F. Kennedy Jr. wants to make them more accessible. The FDA could ease enforcement against US-based peptide makers or move to formal rulemaking. Compounders and biohackers extol peptides for their properties, but some pharmacists and doctors warn of health risks due to lack of scientific data.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.